#patent-expiration-and-generic-access
#patent-expiration-and-generic-access

[ follow ]

Weight-loss jab could be made for $3 a month, study finds

Semaglutide could be manufactured for $3 monthly in injectable form, potentially expanding access to obesity treatment in lower-income countries as patents expire in 160 nations.

[ Load more ]

#patent-expiration-and-generic-access#patent-expiration-and-generic-access

Weight-loss jab could be made for $3 a month, study finds

#patent-expiration-and-generic-access
#patent-expiration-and-generic-access